Dr. Andrew Gabriel Horodner, MD

Dr. Horodner practices at Torrance Memorial Physician Network in Torrance, California.

Dr. Horodner's NPI, 1386849974, was assigned on June 15, 2007. Dr. Horodner graduated from College of Medicine - Tucson in 2001. Dr. Horodner holds California license A81801.

Dr. Horodner's primary practice is Torrance Memorial Physician Network, at 3285 Skypark Dr, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 784-6300.

Dr. Horodner's primary practice is Torrance Memorial Physician Network in Torrance, California. Dr. Horodner is also affiliated with Torrance Memorial Medical Center. The medical group on file is Torrance Memorial Physician Network. Dmand AI also links Dr. Horodner to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horodner practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Horodner's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Horodner is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Horodner treats.

CMS data shows 22,921 Medicare services from Dr. Horodner across 25 procedure codes in 2024, for 365 Medicare patients. Medicare paid $273,595 for them.

CMS counts 365 Medicare patients who saw Dr. Horodner in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horodner's median patient age at 72, with 62% women.

In 2024, Dr. Horodner wrote 1,048 Medicare Part D claims for 198 patients. 65% of them were for generic drugs. CMS names the drug for 827 of them, across 31 drugs with 11 or more claims each, at $3,739,491 in total drug cost. In 2023, CMS named 730 claims across 25 drugs.

Dr. Horodner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Horodner as offering telehealth.

Dmand AI links 3 papers to Dr. Horodner in 2017. 2017 was the busiest year, with 2. Dr. Horodner's most frequent co-authors are Robert Howard Collins, MD, Tatjana Kolevska, MD and Sven De Vos, MD.

Dmand AI links Dr. Horodner to 6 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Acromesomelic dysplasia, Maroteaux type.

CMS Open Payments shows 121 general payments to Dr. Horodner from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $743.

Dmand AI lists 1 award for Dr. Horodner, most recently CMS Stage 1 2012 in 2012.

Dr. Horodner graduated from College of Medicine - Tucson in 2001.

Dr. Horodner is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.